
HQ - New York
Summary
Clinical-stage neuroscience biotech developing innovative, best-in-class new chemical entities that transform the treatment paradigm of psychiatric diseases, moving away from symptom management towards rapid-acting and durable therapies.
Deals Overview
All rights reserved. Copyright © 2026 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Jonathan Sporn
CEO
Laszlo Kiss
CBO and Head of Research